ATTH | Atlas Therapeutics Corporation

Atlas Therapeutics Corp. ATTH

  ATTH traded two-and-a-half times its ten day average volume on Wednesday, as the stock continued to make higher lows; quite the positive sign. The stock managed to close at its high of day, logging a modest gain of 13% on the day.

Pertaining to the chart, the MACD appears to be kissing, and ready for the impending cross that we pointed out yesterday, so we think there is a fair chance to see ATTH finish the week strong.

One of the reasons why we like Atlas, is the employment of Dr. Carlon Colker, the inventor of the company’s flagship product, MYO-T12. Dr. Colker has quite a resume` beyond MYO-T12, including treatment and advisory of some of MMA’s top fighters, and a lead role in R&D for such health supplements as Metabolife, Ripped Fuel, and Xenadrine.
He has also authored several books, and still serves as an attending physician at world renowned medical center Beth Isreal in NY, as well as Greenwich Hospital in Connecticut.
According to Dr. Colker: “Of all the supplements I’ve developed, MYO-T12 is by far, the most effective anti-aging and fitness enhancement product you can buy.”
For those of you that may have missed the short ATTH pdf report we linked yesterday, why not take a look today, it is a good way to begin learning more about this ecxiting company.

ATTH | Atlas Therapeutics Corp. | Hot Stock Today

Atlas Therapeutics Corp. ATTH

  ATTH is our latest interest, and it appears as if conditions on the chart are ripening. A little more than a week ago, the stock appeared to hit a relative bottom at .11. From there, it has started to make higher lows, signaling the start of an uptrend. It has also exhibited higher than average volume, to the tune of 7x its 3mo. average. We currently have support at .11, and resistance at .20, .27 and .30.
  Back in September, the stock ran from .20 to .39, rattling off nearly a 100% increase in just two trading sessions, showing it’s ability to make explosive gains.
  If you take a look at the chart we have provided, you will see also that the MACD indicator is showing signs of convergence, taking on the look of that of a stock about to run.
Take a look at this report on ATTH in .pdf format for your reading convenience. It will provide a good jumping off point for your own due diligence.